文献速递牙周病口腔黏膜病

系统性疾病改变口腔微生物群

The Oral Microbiota Is Modified by Systemic Diseases.
PubMed 文献 · J Dent Res · 2018-10-25

本文综述糖尿病、类风湿关节炎和系统性红斑狼疮等系统性疾病对口腔微生物群的影响。这些疾病增强牙周炎症并增加牙周炎风险或严重度,均与健康相关菌群减少和疾病相关菌群增加有关;动物模型显示糖尿病增加口腔微生物致病性,抑制IL-17可逆转,提示IL-17是关键介质。

要点

  • 糖尿病、RA和SLE均与健康相关菌群减少和疾病相关菌群增加有关。
  • 糖尿病增加Capnocytophaga、Porphyromonas和Pseudomonas水平。
  • RA中Prevotella和Selenomonas增加,SLE中Selenomonas、Leptotrichia和Prevotella增加。

核心结论

  • 以炎症增强为特征的系统性疾病扰乱口腔微生物群,IL-17可能是关键介质。

研究设计与样本

  • 综述人类研究和动物模型,探讨糖尿病、类风湿关节炎和系统性红斑狼疮对口腔微生物群的影响。

主要发现

  • 三种系统性疾病均与健康相关菌群减少和疾病相关菌群增加有关。
  • 糖尿病增加Capnocytophaga、Porphyromonas和Pseudomonas水平;RA中Prevotella和Selenomonas增加;SLE中Selenomonas、Leptotrichia和Prevotella增加。
  • 动物模型中糖尿病增加口腔微生物致病性,转移至正常无菌宿主后炎症、破骨细胞生成和牙周骨丧失增加。
  • 糖尿病动物中抑制IL-17可部分逆转微生物致病性增加;SLE、RA和白细胞黏附缺陷中IL-17增加。
  • 成功的RA抗炎治疗部分逆转口腔微生物失调。

临床怎么用

  • 对糖尿病、RA和SLE患者应关注牙周状况和口腔微生物群变化。
  • IL-17可能作为系统性疾病相关口腔微生物失调的干预靶点。

局限性

  • 每种疾病相关的具体口腔细菌变化仍存在争议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Periodontal diseases are initiated by bacteria that accumulate in a biofilm on the tooth surface and affect the adjacent periodontal tissue. Systemic diseases such as diabetes, rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) increase susceptibility to destructive periodontal diseases. In human studies and in animal models, these diseases have been shown to enhance inflammation in the periodontium and increase the risk or severity of periodontitis. All 3 systemic diseases are linked to a decrease in bacterial taxa associated with health and an increase in taxa associated with disease. Although there is controversy regarding the specific oral bacterial changes associated with each disease, it has been reported that diabetes increases the levels of Capnocytophaga, Porphyromonas, and Pseudomonas, while Prevotella and Selenomonas are increased in RA and Selenomonas, Leptotrichia, and Prevotella in SLE. In an animal model, diabetes increased the pathogenicity of the oral microbiome, as shown by increased inflammation, osteoclastogenesis, and periodontal bone loss when transferred to normal germ-free hosts. Moreover, in diabetic animals, the increased pathogenicity could be substantially reversed by inhibition of IL-17, indicating that host inflammation altered the microbial pathogenicity. Increased IL-17 has also been shown in SLE, RA, and leukocyte adhesion deficiency and may contribute to oral microbial changes in these diseases. Successful RA treatment with anti-inflammatory drugs partially reverses the oral microbial dysbiosis. Together, these data demonstrate that systemic diseases characterized by enhanced inflammation disturb the oral microbiota and point to IL-17 as key mediator in this process.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Graves DT, Corrêa JD, Silva TA, et al. The Oral Microbiota Is Modified by Systemic Diseases. J Dent Res. 2018. PMID: 30359170. doi:10.1177/0022034518805739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。